Kodiak Sciences (KOD)
(Real Time Quote from BATS)
$3.30 USD
+0.28 (9.27%)
Updated Jul 25, 2024 01:06 PM ET
3-Hold of 5 3
D Value B Growth C Momentum C VGM
Balance Sheet
Fiscal Year End for Kodiak Sciences Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 286 | 479 | 732 | 969 | 336 |
Receivables | 0 | 0 | 0 | 0 | 0 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 4 | 7 | 3 | 3 | 3 |
Total Current Assets | 289 | 486 | 735 | 972 | 339 |
Net Property & Equipment | 120 | 56 | 41 | 5 | 1 |
Investments & Advances | 0 | 0 | 0 | 0 | 12 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 15 | 65 | 61 | 17 | 5 |
Total Assets | 479 | 667 | 904 | 1,067 | 359 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 14 | 9 | 12 | 9 | 3 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 18 | 33 | 48 | 20 | 9 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 42 | 53 | 65 | 31 | 12 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 100 | 100 | 100 | 100 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 214 | 230 | 241 | 207 | 14 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 1,418 | 1,330 | 1,222 | 1,152 | 503 |
Retained Earnings | -1,153 | -892 | -558 | -291 | -158 |
Other Equity | 0 | -1 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 266 | 436 | 663 | 861 | 345 |
Total Liabilities & Shareholder's Equity | 479 | 667 | 904 | 1,067 | 359 |
Total Common Equity | 266 | 436 | 663 | 861 | 345 |
Shares Outstanding | 52.40 | 52.30 | 51.70 | 44.80 | 37.00 |
Book Value Per Share | 5.07 | 8.34 | 12.83 | 19.21 | 9.33 |
Fiscal Year End for Kodiak Sciences Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 246 | 286 | 346 | 379 |
Receivables | NA | 0 | 0 | 0 | 0 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 0 | 0 | 0 | 0 |
Other Current Assets | NA | 6 | 4 | 5 | 8 |
Total Current Assets | NA | 252 | 289 | 351 | 387 |
Net Property & Equipment | NA | 116 | 120 | 125 | 130 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 0 | 0 | 0 | 0 |
Deposits & Other Assets | NA | 15 | 15 | 15 | 15 |
Total Assets | NA | 435 | 479 | 548 | 590 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 2 | 14 | 39 | 12 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 13 | 18 | 23 | 54 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 0 | 0 | 0 | 0 |
Total Current Liabilities | NA | 25 | 42 | 71 | 74 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 100 | 100 | 100 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 194 | 214 | 245 | 251 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 1,437 | 1,418 | 1,395 | 1,381 |
Retained Earnings | NA | -1,196 | -1,153 | -1,093 | -1,043 |
Other Equity | NA | 0 | 0 | 0 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 241 | 266 | 302 | 338 |
Total Liabilities & Shareholder's Equity | NA | 435 | 479 | 548 | 590 |
Total Common Equity | 0 | 241 | 266 | 302 | 338 |
Shares Outstanding | 52.50 | 52.50 | 52.40 | 52.40 | 52.30 |
Book Value Per Share | 0.00 | 4.59 | 5.07 | 5.77 | 6.47 |